Statement of Commissioner Maureen K. Ohlhausen before House Energy and Commerce Committee
Date
By
Maureen K. Ohlhausen, Former Commissioner and Former Acting Chair
Displaying 1781 - 1800 of 4878
FTC Submits Statement to HHS on Its Blueprint to Lower Drug Prices
Date
The Federal Trade Commission responded to the U.S. Department of Health and Human Services’ request for comment to its publication, Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. The...
1807004 Informal Interpretation
Date
Rule
Item 2 and Item 3
Yes, our guidance states that size of transaction can be expressed in a range as long as it does not straddle a filing fee threshold.
File
Original Image
(101.95 KB)
FTC Approves Final Order Imposing Conditions on Merger of Generic Drug Marketers Amneal Pharmaceuticals LLC and Impax Laboratories Inc.
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Amneal’s $1.45 billion acquisition of an equity share in Impax likely would be...
Amneal Holdings and Impax Laboratories, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
181 0017
C-4650
1806003 Informal Interpretation
Date
Rule
801.30, 801.2
We view this as an acquisition of B by A with backside acquisitions of A by the B shareholders. Since the agreement is signed by both A and B, it should not be treated as an 801.30 transaction.
File
Original Image
(106.82 KB)
Statement of FTC Chairman Joe Simons Regarding Federal Court Ruling in FTC v. AbbVie
Date
Federal Trade Commission Chairman Joe Simons issued the following statement regarding the decision by the U.S. District Court for the Eastern District of Pennsylvania in the case FTC v. AbbVie. The...
FTC and DOJ Approve Procedural Changes to HSR Form Instructions
Date
The Federal Trade Commission, with the concurrence of the Antitrust Division of the U.S. Department of Justice, has approved amendments to the Hart-Scott-Rodino Premerger Notification Rules and to the...
1806004 Informal Interpretation
Date
Rule
7A, 15 U.S.C. 18a(h)
HSR filings are exempt from public disclosure by the Clayton Act, Sec. 7A, 15 U.S.C. 18a(h). Other than the early termination notices, the Premerger Office and the Antitrust Division’s Premerger Unit...
File
Original Image
(106.06 KB)
Federal Register Notice
1-800 Contacts, Inc. Oral Argument Before the Commission; Oral Argument; Open Meeting Federal Register Notice
Date
Federal Register Notice
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules (May 2018)
Date
Federal Register Notice
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules (April 2018)
Date
Displaying 1781 - 1800 of 4878